[Immunologic diseases--conclusion 10. Immunosuppression, recommendations for ambulatory treatment and supervision].
D000553:Ambulatory Care; D001379:Azathioprine / Q000008:administration & dosage / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007154:Immune System Diseases / Q000188:drug therapy*; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D008134:Long-Term Care; D008297:Male; D011239:Prednisolone / Q000008:administration & dosage / Q000627:therapeutic use
D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D011239:Prednisolone; D001379:Azathioprine
Immunologish bedingte Erkrankungen--Schluss. (Folge)10: Immunsuppression, Empfehlungen für die ambulante Behandlung und Uberwachung